Atomoxetine HCl

Atomoxetine HCl is a norepinephrine reuptake inhibitor that was approved for the treatment of ADHD (attention-deficit hyperactivity disorder). It is proved by X-ray diffraction that Atomoxetine HCl is the R(-) isomer. It is a white to practically white solid.

Brands
STRATTERA STRATTERA STRATTERA STRATTERA ADS ATTENTRA ATTENTRA ATTENTRA
Adult Dose
Neonatal
Paedriatic
Characteristics
. The Molecular Weight of Atomoxetine HCl is 291.82.
Contraindications
Atomoxetine HCl
Effects
The signs and symptoms that are produced after the acute overdosage of Atomoxetine HCl include Agitation, Somnolence, Hyperactivity, Abdominal discomfort.The symptomatic adverse reactions produced by Atomoxetine HCl are more or less tolerable and if they become severe, they can be treated symptomatically, these include Gastrointestinal disturbances.
Indications
Atomoxetine HCl is primarily indicated in conditions like Attention deficit, Hyperactivity Disorder.
Interactions
No data regarding the interactions of Atomoxetine HCl was found.
Interfrence
Risks
If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Atomoxetine is classified as a norepinephrine reuptake inhibitor, and is approved for use in children, adolescents, and adults. However, its efficacy has not been studied in children under six years old. Its advantage over stimulants for the treatment of ADHD is that it has less abuse potential than stimulants, is not scheduled as a controlled substance and has proven in clinical trials to offer 24 hour coverage of symptoms associated with ADHD in adults and children.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.